MJ Biz reports
The British company has been working towards getting the U.S. Food and Drug Administration to sign off on an epileptic medicine called Epidiolex. The company is so confident it will win approval that it announced a move this week to ramp up production. GW Pharmaceuticals believes it will be serving tens of thousands of patients in the United States within the next year or so.
Just let that sink in for a second. A United States federal agency appears poised to formally approve a marijuana-based medicine.
That seemingly simple-sounding incident could have a wide range of ripple effects…. see report